CTRI/2015/03/005616.
Methods | Randomized controlled trial |
Participants | Patients scheduled for elective intracranial surgery, ASA I and II, GCS 15 |
Interventions | Ondansetron (4 mg) given at the time of dural closure or palonosetron (0.075 mg) given at the time of dural closure |
Outcomes | PONV, side effects |
Notes | Study status (recruiting), first posted (2015), missing information (age, anaesthesia regimen, intervention) |